RNA-sequencing as a diagnostic tool in exome negative undiagnosed rare paediatric neurometabolic disorders
Implementing Organization
National Institute Of Mental Health And Neurosciences
Principal Investigator
Dr. Hansashree Padmanabha
National Institute Of Mental Health And Neurosciences
CO-Principal Investigator
Dr. Gautham Arunachal Udupi
National Institute Of Mental Health And Neurosciences
CO-Principal Investigator
Dr. Raghavendra K
National Institute Of Mental Health And Neurosciences
CO-Principal Investigator
Dr. Chetan G K
National Institute Of Mental Health And Neurosciences
CO-Principal Investigator
Dr. Yogananda shamamandriMarkandeya
National Institute Of Mental Health And Neurosciences
CO-Principal Investigator
Prof. Vykuntaraju K Gowda
Institute of Public Health
Project Overview
Inborn errors of metabolism (IEM) are rare inherited disorders that disrupt metabolic pathways, leading to deficiency or accumulation of specific metabolites. They are common in India, with a prevalence of 1:2497 live births. Undiagnosed IEMs contribute to significant morbidity and mortality, and early diagnosis is crucial for family planning, prenatal diagnostic testing, and disease monitoring. Despite extensive molecular investigations, 40 to 50% of children with neurometabolic disorders remain undiagnosed. RNA-sequencing (RNA-seq) has evolved to solve one-third of cases in rare mendelian disorders, but there is a lack of understanding about its role in exome negative neurometabolic disorders in children. This study aims to gain insights into RNA-seq's role in diagnosing exome negative undiagnosed pediatric patients with neurometabolic disorders and study the pathological mechanisms of mitochondrial abnormalities in these patients.